Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...

Bristol Myers Squibb has won the European Commission's expanded approval of its Opdivo plus Yervoy cancer-drug combination for early use in certain patients with liver cancer. Bristol Myers on Friday ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

The groundbreaking study demonstrates drug candidate can safely and effectively target and eliminate senescent cells, also known as “zombie cells,” from the liver.

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020 according to the World ...

Doctors warn, fatty liver can lead to liver cancer if ignored! Here's how to prevent non-alcoholic fatty liver disease.

Discover the 7 major risk factors for liver cancer, from viral hepatitis to genetics. Learn how lifestyle changes and early ...

One of the world's most globally recognised liver cancer treatments will receive public funding from today. Tecentriq ...

Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...

A Whakatāne man with terminal cancer says he has outlived his life expectancy after joining a trial for cancer drugs that ...

Opens in a new tab or window PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans ... as Barcelona Clinical Liver Cancer (BCLC) tumor stage ...